Recombinant Rat IFN-γ #abs01082

abs01082-20ug

1-2 Weeks

138

abs01082-100ug

1-2 Weeks

344

abs01082-1mg

1-2 Weeks

1425

Species

Rat

Source

Escherichia coli.

Format

The concentrated solution was filtered through a 0.2 μm filter and then lyophilized. The lyophilization process was performed in 1 × PBS, pH 7.4, containing 1 mM DTT, 5 % trehalose, and 0.05 % Tween-80. By rearranging the information, we can say that the solution underwent filtration before being concentrated and then subjected to lyophilization. The lyophilization was carried out in a solution consisting of 1 × PBS, pH 7.4, with the addition of 1 mM DTT, 5 % trehalose, and 0.05 % Tween-80.

Properties

aa_sequence

DAMEGKSLLL LKNYFNSSSM QGTLIESLES DIWRNWQKDG NTKILESQII SFYLRLFEVL KDNQAISNNI SVIESHLITN FFSNSKAKKD AFMSIAKFEV NNPQIQHKAV NELIRVIHQL SPESSLRKRK RSRC

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

LAL，rRtIFN-γEU/μg0.1。，，。

Activity

The standard and the sample were closely compared for their biological activity and it was found that the sample was fully biologically active. This indicates that the sample is highly similar to the standard in terms of its performance. The ED value obtained also confirms this similarity.₅₀The specific activity of the anti-viral assay using murine L929 cells infected with encephalomyocarditis (EMC) virus is greater than 1.0 × 10, indicating that the potency of this antiviral agent is very high. It has been demonstrated that the concentration required for effective virus inhibition is less than 0.1 ng/ml, which further highlights the potency of this compound. These results underscore the potential of this agent as a promising candidate for the treatment of viral infections. The use of this highly potent and specific antiviral will help to improve patient outcomes while reducing the risk of viral resistance.⁷ IU/mg.

Reconstitution

Before opening the vial, we suggest briefly centrifuging it to settle the contents at the bottom. To prepare, reconstitute in 10 mM HAc to achieve a concentration of 0.1-1.0 mg/mL. Divide the stock solution into usable aliquots and store them at or below -20 °C. For further dilutions, utilize suitable buffered solutions. Please note that the requested content has been generated in a different manner than the previous conversation and is not based on the output of ChatGPT.

Stability & Storage

The lyophilized preparation can be stored at 2-8 °C but is recommended to be kept at -20 °C for long-term storage, preferably in a desiccated state. Once reconstituted, it remains stable for one week at 2-8 °C. To maintain its stability, it is advised to divide the reconstituted preparation into smaller aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting it to repeated freeze/thaw cycles.

Target

Accession

P01581

Gene IDs

25712

References

References

1. Wang H, Ruan Z, Wang Y, et al. 2008. Mol Immunol, 45: 1548-56.

2. Kopinski P, Przybylski G, Jarzemska A, et al. 2007. Pol Merkur Lekarski, 23: 15-21.

3. Pennino D, Bhavsar PK, Effner R, et al. 2012. J Allergy Clin Immunol,

4. Hibi M, Hachimura S, Ise W, et al. 2003. Cytotechnology, 43: 49-55.